Fuelled by collaboration
At Conscience, we are helping discover new medicines in the open, benchmarking artificial intelligence for computational drug discovery, and creating a community to reinvent how medicines are discovered. No matter who you are, there are ways we can work together.
Learn and participate
Discover our challenges and funding programs for Canadian enterprises, academic institutions, and non-profits.
| Program | Funds | Amount | Eligibility |
| CACHE Challenges | Computational predictions for early-stage drug discovery, lab-tested and published | 50% of participation costs up to $75k CAD | Canadian academics, large enterprises, and SMEs |
| Developing Medicines through Open Science (DMOS) | Preclinical and clinical drug development in areas of unmet medical need (TRL 2–7) | Up to $2M CAD | Must include at least one Canadian SME |
| AI-driven Medicines (AIM) | Computational and digital tools for drug development (TRL 3–7) | Up to $1M CAD | Must include at least one Canadian SME |
| Open Science Advisory Services (OSAS) | Access to third party expertise, e.g. legal, regulatory, CRO, and business strategy advisors | 33% of project costs | Must include at least one Canadian SME, non-profit, or public institution |
- Learn about BEACON, the benchmarking consortium Conscience helped launch alongside CASP, DREAM, and other partners, and how to get involved.
- Take advantage of our free Open Science Guidance Consultations or hire us for more extensive Consultation Services.
- Sign up for our newsletter and follow us on social media to receive updates on computational drug discovery, open drug development, and hear from those in our network.
- Find resources such as presentations, videos, guides, and policy briefs.
- Become a member of the Conscience community.
Support our mission
You can support our work by:
- Sponsoring a CACHE Challenge
- Joining the CACHE Governing Board
- Becoming a co-funder for our DMOS program
- Becoming an Institutional Member of the Conscience community
Get in touch
To learn more, reach out at [email protected] or fill in our contact form by clicking the button below.
